Number of pages: 100 | Report Format: PDF | Published date: April 10, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
Report Attribute |
Details |
Market Size Value in 2022 |
US$ 3.48 billion |
Revenue Forecast in 2031 |
US$ 19.87 billion |
CAGR |
21.35% |
Base Year For Estimation |
2022 |
Forecast Period |
2023 to 2031 |
Historical Year |
2021 |
Segments Covered |
Type of Containers, Application, End User, and Region |
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global bioprocess containers market was valued at US$ 3.48 billion in 2022 and is expected to register a revenue CAGR of 21.35% to reach US$ 19.87 billion by 2031.
Bioprocess Containers Market Fundamentals
Bioprocess containers are disposable, flexible containers used to manufacture biopharmaceuticals, vaccines, and other biological products. They are constructed of sterile and biocompatible plastic or polymer materials such as polyethylene, polypropylene, or ethylene vinyl acetate (EVA). Cell culture, medium preparation, storage, and transportation of biological materials are all possible uses for these containers. They are widely utilized in biopharmaceuticals because they have several advantages over standard glass or stainless-steel containers, including decreased contamination risk, cheaper cleaning and sterilizing expenses, and enhanced production process flexibility.
The bioprocess containers market is likely to experience significant revenue growth due to rising demand for biopharmaceutical products and the biopharmaceutical industry's shift toward single-use production methods. To decrease the risk of contamination and boost production flexibility, the biopharmaceutical sector is rapidly using single-use technology, such as bioprocess containers. The trend toward personalized medicine is expected to enhance demand for bioprocess containers in the future, as these containers may be modified to match the needs of individual patients.
Moreover, bioprocess container players are taking several steps to enhance the market and meet the evolving needs of the biopharmaceutical industry. For instance, many market players emphasize more on sustainability by using eco-friendly materials and minimizing waste. This helps biopharmaceutical manufacturers reduce their environmental impact and meet sustainability goals. In addition, some market players are also investing in research and development activities to introduce innovative products that offer better performance and cost-effectiveness. These efforts are expected to drive the revenue growth of the bioprocess containers market during the forecast period.
[6787565]
Bioprocess Containers Market Dynamics
The increasing demand for biopharmaceuticals and personalized medicine is augmenting the growth bioprocess containers market. Bioprocess containers are designed to provide a sterile environment for the production of biopharmaceuticals. They are highly customizable, which makes them suitable for personalized medicine. Bioprocess containers contain and transport biological materials such as cell lines, proteins, and vaccines, which are crucial in manufacturing customized medication. Additionally, personalized medicine demands the production of smaller batches of pharmaceuticals and biologics customized for particular patients, requiring manufacturers to be more flexible and agile in their manufacturing processes.
Increased adoption of single-use technologies contributes to the bioprocess containers industry demand. The single-use technology (SUT) products are frequently used in vaccine and biological manufacture. The purity and efficacy of final biopharmaceutical therapeutic products depend on the quality and purity of the polymers used to manufacture. For instance, Thermo Scientific's BioProcess Containers (BPCs) are becoming more popular due to their proven performance and cost- and time-saving benefits.
Furthermore, various market expansion strategies conducted by top players operating in the area, such as expansion, mergers, acquisitions, and partnerships, are likely to drive growth in the bioprocess containers market during the forecast period. For example, in June 2022, AstraZeneca's Rare Disease subsidiary, Alexion, announced a EUR 65 million investment in Ireland to enhance its manufacturing capabilities. The funding would build the company's biological production capacity and improve R&D projects. Bioprocess containers are easily incorporated into various high-performance systems throughout biological manufacturing. The key global bioprocess containers market challenge is the high cost associated with single-use bioprocess containers and concerns regarding their environmental impact. Additionally, the bioprocess containers market may experience some limitations due to the high cost of raw materials and the need for specialized equipment for production. Moreover, strict regulations on using single-use bioprocess containers may also somewhat hinder market revenue growth.
Bioprocess Containers Market Ecosystem
The global bioprocess containers market is analyzed from four perspectives: type of containers, application, end user, and region.
Bioprocess Containers Market by Type
[86987]
Based on the types, the global bioprocess containers market is segmented into 2D bioprocess containers, 3D bioprocess containers, and others.
In 2022, the 2D bioprocess container segment led the global bioprocess containers market in terms of revenue share. 2D bioprocess containers are commonly used to carry large amounts of medicinal products and precursors and harvest cells. These containers assist in biopharmaceutical manufacturing by aiding in fluid management, media preparation, and storage. Additionally, 2D bioprocess containers are designed to maintain a sterile environment, prevent contamination, and ensure the final product's safety and efficacy. They are also cost-effective and environmentally friendly alternatives to traditional glass containers.
However, the 3D bioprocess container segment is expected to show lucrative revenue growth during the forecast years. The 3D bioprocess containers are a novel approach for storing and transporting biologics, vaccines, and other sensitive products. These containers create a sterile environment that can keep the contents intact throughout transportation and storage.
Bioprocess Containers Market by Application
Based on the application, the global bioprocess containers market is segmented into upstream, downstream, and process development.
The upstream process segment accounted majority of the global bioprocess containers market revenue share in 2022. Bioprocess containers play an important role in the upstream process of biopharmaceutical manufacturing as these containers provide a sterile environment for cell growth and biomolecule creation. Furthermore, these containers are available in various shapes and materials, including stainless steel tanks and single-use plastic bags, to meet varying production scales and demands.
The downstream process segment is expected to grow in terms of revenue share highly during the forecast period. Bioprocess containers are critical in downstream processes because they provide a sterile and regulated environment for biopharmaceutical product storage and delivery. They also maintain the end product's integrity and quality, reducing the danger of contamination and assuring compliance with regulatory standards. These containers are made of biocompatible materials and are available in various volumes to meet the specific needs of various operations. Additionally, they are designed for single use, reducing the need for cleaning and sterilizing and saving time and money.
Bioprocess Containers Market by End User
Based on end users, the global bioprocess containers market is segmented into pharmaceutical & biopharmaceutical companies, academic & research institutes, and CROs & CMOs.
In 2022, the pharmaceutical & biopharmaceutical companies segment will lead the global bioprocess containers market. Bioprocess containers are required to safely and safely store and transport biopharmaceutical products. These equipment are intended to fulfill the pharmaceutical companies' strict standards, offering a dependable option for handling delicate biological products. Moreover, the R&D procedures frequently require bioprocess containers to store media.
Bioprocess containers are widely used in academic and research institutions for manufacturing vaccines, monoclonal antibodies, and other biopharmaceuticals. These containers provide a sterile and regulated environment for cell growth and production, which are important in bioprocessing research. Furthermore, these containers are composed of materials compatible with various cell types and may be scaled up or down depending on manufacturing requirements.
Bioprocess Containers Market by Region
Based on the region, the global bioprocess containers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounted for the highest revenue share in 2022. The bioprocess containers market revenue in North America is also expected to grow significantly during the forecast period due to the increasing demand for biopharmaceuticals and the rising adoption of single-use technologies. The growing number of biopharmaceutical companies and the need for cost-effective manufacturing processes are also driving the revenue growth of this market. Moreover, the increasing demand for personalized medications is also supporting the market revenue growth in this region. Additionally, the rising prevalence of chronic diseases and the need for advanced treatment options further promote the revenue growth of the biopharmaceutical market in North America. This is expected to create lucrative opportunities for market players in the coming years.
The European bioprocess containers market is characterized by the presence of established players and a growing demand for single-use technologies. The presence of many top market players in the region and increased research and development is expected to increase the global bioprocess containers market. Additionally, the adoption of bioprocess containers in the pharmaceutical and biotechnology industries is expected to drive market revenue growth during the forecast due to their cost-effectiveness and efficiency in reducing contamination risks. The increasing demand for personalized medicine and biologics in the region will further support this trend.
The bioprocess containers market in the Asia Pacific is expected to observe significant revenue growth during forecast years due to the increased launch of many biopharmaceutical companies in the region and rising research and development for producing novel drugs. Furthermore, increasing government initiatives and funding for regional research and development activities is also expected to drive the global bioprocess containers market revenue growth. The growing demand for biologics and biosimilars is also expected to boost the market revenue growth in the Asia Pacific region. Additionally, the increasing adoption of single-use technologies for bioprocessing will likely create lucrative opportunities for market players in the Asia Pacific.
Competitive Landscape of the Global Bioprocess Containers Market
The bioprocess containers market is highly competitive, with several established players and new entrants. The key players focus on strategic partnerships, collaborations, and acquisitions to expand their product portfolio and increase their market share. Moreover, the increasing demand for bioprocess containers due to the rising adoption of single-use technologies in biopharmaceutical manufacturing is expected to drive market revenue growth further. The growing trend of outsourcing biopharmaceutical production activities to contract manufacturing organizations (CMOs) is also expected to create lucrative opportunities for market players in the coming years.
Some of the prominent companies operating in the global bioprocess containers market are:
Strategic Developments in Bioprocess Containers Market
The bioprocess containers market is expected to experience significant revenue growth due to the increasing demand for biopharmaceuticals and personalized medicine. Additionally, the adoption of single-use technologies and the need for cost-effective manufacturing processes are also driving the revenue growth of this market.
The global bioprocess containers market was valued at US$ 3.48 billion in 2022.
Some of the major strategies the key players adopt in the bioprocess containers market include mergers and acquisitions, product launches, partnerships, and collaborations.
The upstream process segment accounted majority of the global bioprocess containers market revenue share in 2022.
The global bioprocess containers market was valued at US$ 3.48 billion in 2022 and is expected to register a revenue CAGR of 21.35% by 2031.
*Insights on financial performance are subject to the availability of information in the public domain